A phase I study of GLPG 2665 in patients with cystic fibrosis
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2015
At a glance
- Drugs GLPG 2665 (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Galapagos NV
- 13 Nov 2015 According to Galapagos media release, this trial is expected to start before end of 2015.
- 13 Nov 2015 Planned initiation date changed from 1 Jun 2016 to 1 Dec 2015, according to Galapagos media release.
- 19 Oct 2015 New trial record